LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 96 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $130,946 | -10.8% | 110,975 | +6.6% | 0.00% | – |
| Q2 2023 | $146,762 | -6.5% | 104,087 | +2.3% | 0.00% | – |
| Q1 2022 | $157,000 | -46.8% | 101,742 | -15.5% | 0.00% | – |
| Q4 2021 | $295,000 | -1.3% | 120,434 | +1.4% | 0.00% | – |
| Q3 2021 | $299,000 | -6.9% | 118,723 | +5.5% | 0.00% | – |
| Q2 2021 | $321,000 | +115.4% | 112,515 | -37.6% | 0.00% | – |
| Q1 2020 | $149,000 | -7.5% | 180,344 | 0.0% | 0.00% | – |
| Q4 2019 | $161,000 | -9.0% | 180,344 | +0.1% | 0.00% | – |
| Q3 2019 | $177,000 | – | 180,201 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,935,485 | $41,223,872 | 3.66% |
| Raffles Associates | 1,587,739 | $1,873,532 | 2.48% |
| Defender Capital, LLC. | 5,184,510 | $6,117,722 | 2.22% |
| Prescott General Partners LLC | 1,851,851 | $2,185,184 | 0.14% |
| DCF Advisers, LLC | 82,751 | $97,646 | 0.05% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $63,450 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 781,766 | $922,484 | 0.02% |
| Fort Sheridan Advisors LLC | 83,931 | $99,039 | 0.02% |
| MAI Capital Management | 954,688 | $1,126,532 | 0.02% |
| Piscataqua Savings Bank | 12,499 | $14,623 | 0.01% |